Acinetobacter baumannii resistance to carbapenem antibiotics is a serious clinical
challenge. As a newly developed technology, silver nanoparticles (AgNPs) show some …

Silver nanoparticles (AgNPs) are widely used for their antibacterial properties due to the
expected benefit of long-term antibacterial efficacy and low potential for bacterial resistance …

Background The development of nontoxic methods of synthesizing nanoparticles is a major
step in nanotechnology to allow their application in nanomedicine. The present study aims …

Acinetobacter baumannii has emerged as one of the major nosocomial pathogens
implicated in variety of severe infections and mortality. It is rapidly developing multi-drug …

Antibiotics used to treat bacterial infections can become ineffective over time or result in the
emergence of antibiotic resistant pathogens. With the advent of nanotechnology, silver …

We aimed to isolate Acinetobacter baumannii (A. baumannii) from wound infections,
determine their resistance and virulence profile, and assess the impact of Silver …

Infections caused by drug-resistant microorganisms result in significant increases in
mortality, morbidity, and cost related to prolonged treatments. The antibacterial activity of …

The ability of microorganisms to generate resistance outcompetes with the generation of
new and efficient antibiotics; therefore, it is critical to develop novel antibiotic agents and …

Microbial resistance to antibiotics is one of the key challenges that lead to the search for
alternate antimicrobial treatment approaches. Silver nanoparticles (AgNPs) are well known …

Nanotechnology is being investigated for its potential to improve nanomedicine for human
health. The purpose of this study was to isolate carbapenemase-producing Gram-negative …